RATIONALE: Anti-ulcer drugs, such as proton pump inhibitors (PPI), are widely prescribed and used in developed countries worldwide. Recently concerns about the promotion of allergic sensitizations following gastric pH modulation have been raised in mechanistic and observational studies. We aimed to assess the frequency of anti-allergic drug prescription following gastric acid inhibitors use in a population-wide study in Austria. METHODS: In this cross-sectional study, age and gender controlled data from health insurance claim records between 2009 and 2013, covering 8.2 million subjects (approx. 97% of the Austrian population), were analyzed regarding prescriptions of i) gastric acid inhibitors (PPI, H2-receptor antagonists, sucralfate, prostaglandin E2) and anti-allergic medication (antihistamines, desensitization therapy). Other commonly prescribed drugs (lipid-modifying and antihypertensive substances) served as controls by Cox regression in a regional subgroup. RESULTS: Prescription of anti-allergic drugs following gastric acidinhibitors showed a rate ratio of 1.96 (95%CI:1.95-1.97) in overall Austrian data and 3.07 (95%-CI:2.89-3.27) in the regional data set, which was more prominent in women (P<0.001). Age and gender adjusted hazard ratio was found to be 2.05 (95%CI:1.91-2.19), and was elevated independent of prescribed gastric acid-inhibiting substances. Further, rate ratios increased from 1.47 (95%CI:1.45-1.49) in subjects <20 years of age, to 5.20 (95%-CI:5.15-5.25) in >60 year olds. CONCLUSIONS: The increased use of anti-allergy medication subsequent to gastric acid suppression suggests an association with the occurrence of allergic symptoms. Prescription of anti-ulcer drugs should be restricted to cases with clear indication and adequate diagnosis to minimize the risk for allergic comorbidities.
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Allergy, depression and quality of life among pregnant women in the Japan Environment and Childrens Study (JECS) METHODS: This is a cross-sectional study within a birth cohort. Lifetime prevalence of allergic disease was assessed on the basis of a self-reported doctor's diagnosis from the questionnaire. Serum total and allergenspecific IgE titers were assayed by ImmunoCAP. Kessler's K-6 NonSpecific Psychological Distress Scale (K-6) was used to evaluate maternal anxiety and depression. Health-related quality of life was measured using the Medical Outcomes Survey Short Form-8 questionnaire (1)(2)(3). Our own large data study showed asthma to be protective against cancer diagnoses. This study aimed to examine association between personal histories of hay fever and cancer, as diagnosed by a physician, in the National Health Interview Survey (NHIS) from 2015. METHODS: This is a cross sectional cohort study. NHIS data from 2015 was analyzed using bivariate analysis between demographic variables, Hay fever and cancer, defined as ever being told they had these conditions by a doctor or health care professional. Covariates included age, sex, race and obesity. Nested multivariate logistic regression model was conducted. All statistical analysis was done using SAS v9.4. RESULTS: Data available for 33,672 adults. Odds of cancer diagnosis with a history of ever having Hayfever was 0.62 (95% CI 0.56-0.69), P<.0001. After adjustment for age, sex, race and obesity, the odds remained similar at 0.67 (95%CI 0.60-0.75) p<.0001. CONCLUSIONS: This study found that a personal history of hayfever, a marker of atopy, was a strong and significant protective factor for cancer diagnosis, a finding in line with our previous finding that asthma was protective of cancers, suggesting an altered immune responses in atopics is protective against cancer.
